Coronavirus Disease-Associated Pulmonary Aspergillosis: A Devastating Complication of COVID-19
- PMID: 33659135
- PMCID: PMC7919614
- DOI: 10.7759/cureus.13004
Coronavirus Disease-Associated Pulmonary Aspergillosis: A Devastating Complication of COVID-19
Abstract
Coronavirus disease-19 (COVID-19) has affected more than ninety-three million people worldwide till January 2021. COVID-19 can cause a destructive dysregulated immune response which can result in numerous complications such as kidney failure, myocarditis, and strokes. A new entity called coronavirus disease-associated pulmonary aspergillosis (CAPA) has emerged in recent times. The literature on CAPA is limited. We present a case of CAPA in an immunocompetent patient who was placed on veno-venous extra-corporeal membranous oxygen (VV-ECMO). We briefly explained pathophysiology, clinical presentations, and management of CAPA in this report.
Keywords: corona virus disease 2019 (covid-19); immuno-competent; invasive aspergillosis; vv-ecmo.
Copyright © 2021, Nasrullah et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f49/7919614/e829477495f6/cureus-0013-00000013004-i01.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f49/7919614/32d872299241/cureus-0013-00000013004-i02.gif)
Similar articles
-
COVID-19-Associated Pulmonary Aspergillosis (CAPA).J Intensive Med. 2021 Aug 7;1(2):71-80. doi: 10.1016/j.jointm.2021.07.001. eCollection 2021 Oct. J Intensive Med. 2021. PMID: 36785564 Free PMC article. Review.
-
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.Ann Thorac Med. 2024 Jan-Mar;19(1):87-95. doi: 10.4103/atm.atm_190_23. Epub 2024 Jan 25. Ann Thorac Med. 2024. PMID: 38444990 Free PMC article.
-
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.Infection. 2022 Feb;50(1):43-56. doi: 10.1007/s15010-021-01701-x. Epub 2021 Sep 27. Infection. 2022. PMID: 34570355 Free PMC article. Review.
-
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate.Open Forum Infect Dis. 2022 Mar 3;9(5):ofac081. doi: 10.1093/ofid/ofac081. eCollection 2022 May. Open Forum Infect Dis. 2022. PMID: 35386295 Free PMC article.
-
COVID-19-Associated Pulmonary Aspergillosis (CAPA) in Northern Greece during 2020-2022: A Comparative Study According to the Main Consensus Criteria and Definitions.J Fungi (Basel). 2023 Jan 5;9(1):81. doi: 10.3390/jof9010081. J Fungi (Basel). 2023. PMID: 36675902 Free PMC article.
Cited by
-
Fungal Colonization and Infections-Interactions with Other Human Diseases.Pathogens. 2022 Feb 6;11(2):212. doi: 10.3390/pathogens11020212. Pathogens. 2022. PMID: 35215155 Free PMC article. Review.
-
Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.Health Sci Rep. 2022 Aug 18;5(5):e789. doi: 10.1002/hsr2.789. eCollection 2022 Sep. Health Sci Rep. 2022. PMID: 36000078 Free PMC article.
-
COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021.J Fungi (Basel). 2021 Nov 10;7(11):948. doi: 10.3390/jof7110948. J Fungi (Basel). 2021. PMID: 34829235 Free PMC article.
-
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients.J Fungi (Basel). 2021 Sep 2;7(9):720. doi: 10.3390/jof7090720. J Fungi (Basel). 2021. PMID: 34575758 Free PMC article. Review.
-
Invasive Fungal Infections Complicating COVID-19: A Narrative Review.J Fungi (Basel). 2021 Oct 29;7(11):921. doi: 10.3390/jof7110921. J Fungi (Basel). 2021. PMID: 34829210 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources